TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 300nMAssay Description:In vitro inhibition of human alphaV-beta3 integrin binding in ELISAMore data for this Ligand-Target Pair